BRONCHIOLITIS OBLITERANS
Clinical trials for BRONCHIOLITIS OBLITERANS explained in plain language.
Never miss a new study
Get alerted when new BRONCHIOLITIS OBLITERANS trials appear
Sign up with your email to follow new studies for BRONCHIOLITIS OBLITERANS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Early halt for transplant lung disease drug trial
Disease control TerminatedThis early-stage study tested the safety of a drug called itacitinib for patients who developed a serious lung scarring condition (bronchiolitis obliterans) after a donor stem cell transplant. The trial aimed to see if the drug could help control this complication and improve pat…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New hope to protect young lungs after Life-Saving transplants
Disease control TerminatedThis study tested whether a specific inhaled medication (a combination of fluticasone and salmeterol) could help improve lung function in children aged 6-17 who had received a stem cell transplant and were showing early signs of lung decline. The goal was to see if this treatment…
Matched conditions: BRONCHIOLITIS OBLITERANS
Phase: PHASE3 • Sponsor: Assistance Publique - Hôpitaux de Paris • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC